Sort   by:  
 Page size 
UnknownEarly life socioeconomic position and immune response to persistent infections among elderly Latinos.
Not available
S-EPMC5573138 | biostudies-literature
UnknownPTSD is associated with an increase in aged T cell phenotypes in adults living in Detroit.
Not available
S-EPMC4826331 | biostudies-literature
UnknownFemtosecond Laser-Assisted Cataract Surgery Versus Phacoemulsification Cataract Surgery (FACT): A Randomized Noninferiority Trial.
Not available
S-EPMC7397499 | biostudies-literature
UnknownPsychiatric disorders converge on common pathways but diverge in cellular context, spatial distribution, and directionality of genetic effects.
Not available
S-EPMC12338884 | biostudies-literature
UnknownAssociation of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
Not available
S-EPMC5567793 | biostudies-literature
UnknownEffects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867 | biostudies-literature
UnknownLong-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743 | biostudies-literature
UnknownEffects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591 | biostudies-literature
UnknownImpact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536 | biostudies-literature
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
Sort   by:  
 Page size